Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|May 31, 2021
Rituximab Associated Hypogammaglobulinemia in Autoimmune DiseaseJoanna Tieu, Rona M Smith, Seerapani Gopaluni, et al.
Annals of the Rheumatic Diseases|June 29, 2018
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitisAndreas Kronbichler, Julia Kerschbaum, Seerapani Gopaluni, et al.
Journal of Autoimmunity|January 6, 2015
Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune diseaseDarren M Roberts, Rachel B Jones, Rona M Smith, et al.
Arthritis and Rheumatism|June 26, 2012
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith, Rachel B Jones, Mary-Jane Guerry, et al.
Trials|March 9, 2017
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trialSeerapani Gopaluni, Rona M Smith, Michelle Lewin, et al.
Nature Reviews. Rheumatology|June 5, 2025
Advances in the treatment of ANCA-associated vasculitisGiorgio Trivioli, Marta Casal Moura, Andreas Kronbichler, et al.
Rheumatology (Oxford, England)|December 6, 2014
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitisFederico Alberici, Rona M Smith, Rachel B Jones, et al.
BMC Musculoskeletal Disorders|June 3, 2014
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune diseaseHelena Marco, Rona M Smith, Rachel B Jones, et al.
Rheumatology (Oxford, England)|November 3, 2020
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction modelsMark E McClure, Yajing Zhu, Rona M Smith, et al.
Rheumatology Advances in Practice|August 21, 2024
Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)Lisa Uchida, Rachel B Jones, Rona M Smith, et al.
Pageof 4